XIV

Source 📝

The Lazzaro Spallanzani National Institute for Infectious Diseases (Italian: Istituto nazionale per le malattie infettive "L. Spallanzani") is an infectious disease hospital in the Italian city of Rome. The institute is named for the eighteenth-century Italian biologist Lazzaro Spallanzani.

It is the Italian national reference center for Ebola patients.

During the COVID-19 pandemic, the Spallanzani Institute was the first research centre in Europe to isolate the genomic sequence of SARS-CoV-2 and upload it to GenBank. The team was composed of Maria Rosaria Capobianchi, Francesca Colavita. And Concetta Castilletti.

The institute is working with biotech company ReiThera to test a COVID-19 vaccine candidate called GRAd-COV2, which is based on a modified gorilla adenovirus vector.

References

External links

41°51′58″N 12°27′27″E / 41.8662°N 12.4576°E / 41.8662; 12.4576


Stub icon

This article about a hospital in Europe is a stub. You can help XIV by expanding it.

Stub icon

This article about COVID-19 vaccines is a stub. You can help XIV by expanding it.

Stub icon

This article about an Italian building or structure is a stub. You can help XIV by expanding it.

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.